GSK starts $2.6 billion tender offer for Human Genome

LONDON (Reuters) - GlaxoSmithKline launched its promised $2.6 billion tender for shares in long-time partner Human Genome Sciences on Thursday, setting out an initial timetable of just under a month t…
Read the full story: Reuters: Health News